Pomalidomide, dexamethasone, and daratumumab immediately after lenalidomide-based treatment in patients with multiple myeloma: updated efficacy, safety, and health-related quality of life results from the phase 2 MM-014 trial.
Saved in:
| Title: | Pomalidomide, dexamethasone, and daratumumab immediately after lenalidomide-based treatment in patients with multiple myeloma: updated efficacy, safety, and health-related quality of life results from the phase 2 MM-014 trial. |
|---|---|
| Authors: | Bahlis, Nizar J.1 (AUTHOR), Siegel, David S.2 (AUTHOR), Schiller, Gary J.3 (AUTHOR), Samaras, Christy4 (AUTHOR), Sebag, Michael5 (AUTHOR), Berdeja, Jesus6 (AUTHOR), Ganguly, Siddhartha7 (AUTHOR), Matous, Jeffrey8 (AUTHOR), Song, Kevin9 (AUTHOR), Seet, Christopher S.3 (AUTHOR), Acosta-Rivera, Mirelis10 (AUTHOR), Bar, Michael11 (AUTHOR), Quick, Donald12 (AUTHOR), Anz, Bertrand13 (AUTHOR), Fonseca, Gustavo14 (AUTHOR), Chung, Weiyuan15 (AUTHOR), Lee, Kim15 (AUTHOR), Mouro, Jorge16 (AUTHOR), Agarwal, Amit15 (AUTHOR), Reece, Donna17 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Jun2022, Vol. 63 Issue 6, p1407-1417. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 157177010 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pomalidomide, dexamethasone, and daratumumab immediately after lenalidomide-based treatment in patients with multiple myeloma: updated efficacy, safety, and health-related quality of life results from the phase 2 MM-014 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Bahlis%2C+Nizar+J%2E%22">Bahlis, Nizar J.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Siegel%2C+David+S%2E%22">Siegel, David S.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schiller%2C+Gary+J%2E%22">Schiller, Gary J.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Samaras%2C+Christy%22">Samaras, Christy</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sebag%2C+Michael%22">Sebag, Michael</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berdeja%2C+Jesus%22">Berdeja, Jesus</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ganguly%2C+Siddhartha%22">Ganguly, Siddhartha</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Matous%2C+Jeffrey%22">Matous, Jeffrey</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Song%2C+Kevin%22">Song, Kevin</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Seet%2C+Christopher+S%2E%22">Seet, Christopher S.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Acosta-Rivera%2C+Mirelis%22">Acosta-Rivera, Mirelis</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bar%2C+Michael%22">Bar, Michael</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Quick%2C+Donald%22">Quick, Donald</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Anz%2C+Bertrand%22">Anz, Bertrand</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fonseca%2C+Gustavo%22">Fonseca, Gustavo</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chung%2C+Weiyuan%22">Chung, Weiyuan</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lee%2C+Kim%22">Lee, Kim</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mouro%2C+Jorge%22">Mouro, Jorge</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Agarwal%2C+Amit%22">Agarwal, Amit</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Reece%2C+Donna%22">Reece, Donna</searchLink><relatesTo>17</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Leukemia+%26+Lymphoma%22">Leukemia & Lymphoma</searchLink>. Jun2022, Vol. 63 Issue 6, p1407-1417. 11p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=157177010 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2022.2030477 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 11 StartPage: 1407 Titles: – TitleFull: Pomalidomide, dexamethasone, and daratumumab immediately after lenalidomide-based treatment in patients with multiple myeloma: updated efficacy, safety, and health-related quality of life results from the phase 2 MM-014 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bahlis, Nizar J. – PersonEntity: Name: NameFull: Siegel, David S. – PersonEntity: Name: NameFull: Schiller, Gary J. – PersonEntity: Name: NameFull: Samaras, Christy – PersonEntity: Name: NameFull: Sebag, Michael – PersonEntity: Name: NameFull: Berdeja, Jesus – PersonEntity: Name: NameFull: Ganguly, Siddhartha – PersonEntity: Name: NameFull: Matous, Jeffrey – PersonEntity: Name: NameFull: Song, Kevin – PersonEntity: Name: NameFull: Seet, Christopher S. – PersonEntity: Name: NameFull: Acosta-Rivera, Mirelis – PersonEntity: Name: NameFull: Bar, Michael – PersonEntity: Name: NameFull: Quick, Donald – PersonEntity: Name: NameFull: Anz, Bertrand – PersonEntity: Name: NameFull: Fonseca, Gustavo – PersonEntity: Name: NameFull: Chung, Weiyuan – PersonEntity: Name: NameFull: Lee, Kim – PersonEntity: Name: NameFull: Mouro, Jorge – PersonEntity: Name: NameFull: Agarwal, Amit – PersonEntity: Name: NameFull: Reece, Donna IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: Jun2022 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 10428194 Numbering: – Type: volume Value: 63 – Type: issue Value: 6 Titles: – TitleFull: Leukemia & Lymphoma Type: main |
| ResultId | 1 |